rss
Br J Ophthalmol 2007;91:620-623 doi:10.1136/bjo.2006.103135
  • Clinical science
    • Scientific reports

Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisation

  1. Alfonso Giovannini,
  2. Piergiorgio Neri,
  3. Lucia Mercanti,
  4. Claudia Bruè
  1. Neuroscience Department—Ophthalmology Section, Polytechnic University of Marche, Ancona, Italy
  1. Correspondence to: Dr P Neri Clinica Oculistica, Azienda Ospedaliera Universitaria, Ospedali Riuniti di Ancona, Via Conca 71, 60100 Torrette-Ancona, Italy; doctor_blacks{at}hotmail.com
  • Accepted 13 December 2006
  • Published Online First 3 January 2007

Abstract

Aim: To compare photodynamic therapy (PDT) with PDT associated with systemic steroids (SS) for the control of juxta/subfoveal idiopathic choroidal neovascularisation (ICNV).

Methods: Patients with juxta/subfoveal ICNV were randomised and then treated. Visual gain and loss were defined as improvement in or worsening for two or more lines of best-corrected visual acuity (BCVA), respectively. Choroidal neovascularisation size after treatment was classified as “increased” and “reduced” if it was increased or reduced by >200 μm2, respectively.

Results: 10 patients were treated with PDT, 10 with SS followed by PDT. The median follow-up time was 22 and 21 months for the “steroid+PDT group” and the “PDT group”, respectively. At 1 year, in the PDT group, five patients had stable/improved BCVA, and five became worse; the mean number of PDT was 2.3; in the steroid+PDT group, all patients were stable/improved and the mean number of PDT was 1.2. The difference between the two groups was significant (p<0.05). At 1 year, the ICNV size after treatment was better in the steroid+PDT group than in the PDT group (p<0.05).

Conclusion: The use of SS before PDT has shown better BCVA outcome than PDT alone (p<0.05), reducing the mean number of PDT applications (1.2 vs 2.3, respectively), with smaller scar size.

Footnotes

  • Published Online First 3 January 2007

  • Sponsors: None.

  • Competing interests: None.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. bjo.2006.103135v1
    2. 91/5/620 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.